The role of visual outcomes in MS clinical trials

被引:0
|
作者
Balcer, L. J. [1 ]
机构
[1] NYU, Sch Med, Neurol, New York, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
TC12.3
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [21] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
    Cindy J. Nowinski
    Deborah M. Miller
    David Cella
    Neurotherapeutics, 2017, 14 : 934 - 944
  • [22] THE EMERGING ROLE OF PATIENT-REPORTED OUTCOMES (PROS) IN CLINICAL TRIALS IN INDIA
    Bn, V
    Naidu, M.
    Esam, H.
    Badgujar, L.
    Kinra, G.
    Dang, A.
    VALUE IN HEALTH, 2015, 18 (03) : A102 - A102
  • [23] The role of anaesthetics in cancer outcomes: do we need more clinical trials?
    Nunez-Rodriguez, Eduardo
    Ramirez, Maria F.
    Cata, Juan P.
    ANAESTHESIA, 2025, 80 (04) : 353 - 356
  • [24] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
    Nowinski, Cindy J.
    Miller, Deborah M.
    Cella, David
    NEUROTHERAPEUTICS, 2017, 14 (04) : 934 - 944
  • [25] The role of clinical neurophysiology in clinical trials
    Olney, RK
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 1998, 15 (02) : 95 - 95
  • [27] Predictors of relapse rate in MS clinical trials
    Held, U
    Heigenhauser, L
    Shang, C
    Kappos, L
    Polman, C
    NEUROLOGY, 2005, 65 (11) : 1769 - 1773
  • [28] Clinical trial design for progressive MS trials
    Pardini, Matteo
    Cutter, Gary
    Sormani, Maria Pia
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1642 - 1648
  • [29] Clinical outcome measures for progressive MS trials
    Ontaneda, Daniel
    Cohen, Jeffrey A.
    Amato, Maria Pia
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1627 - 1635
  • [30] Analysis of count data in ms clinical trials
    Healy, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 73 - 74